![[logo] HealthTree Foundation](https://static.healthtree.org/icons/icon_spinner.svg){kind=icon}
![[logo] HealthTree Foundation](https://static.healthtree.org/logo_icon_only.svg){kind=icon}
Douglas Tremblay, MD
AML Specialist
Specialities: Chronic Myelomonocytic Leukemia, Myelofibrosis, Myelodysplastic Syndromes, Acute Myeloid Leukemia
Spoken languages: English
Clinical Expertise
- Acute Myeloid Leukemia
- Myelofibrosis
- Myelodysplastic Syndromes
- Acute Lymphoid Leukemia
About
Dr. Tremblay has led multi-institutional research efforts in myeloproliferative neoplasms and is actively involved in both investigator-initiated and industry sponsored early and late phase clinical trials in myeloid neoplasms.
Location
Mount Sinai Health System: 1470 Madison Ave #6th, New York, NY 10029, USA
All HealthTree resources available anywhere, anytime
Download our App
Get the Latest Non-Hodgkin Lymphoma Updates, Delivered to You.
By subscribing to the HealthTree newsletter, you'll receive the latest research, treatment updates, and expert insights to help you navigate your health.
Download our App
HealthTree Foundation is a qualified 501(c)(3) tax-exempt organization.
Copyright © 2025 HealthTree Foundation. All rights reserved.
Tax ID 45-5354811